argenx SE (ARGX) stock analysis

In our weekly check, argenx SE is graded A (A to F). Of 23 checks on debt, profit, cash flow and trend: 19 pass, warnings: 4, red flags: 0.

About argenx SE

argenx SE is a Healthcare company (Biotechnology) based in the Netherlands, listed on NASDAQ as ARGX.

What our checks show for ARGX

Warning signs

Strengths

Similar companies

ONC · MRNA · RVMD · REGN · GMAB · ROIV

Questions

What grade does argenx SE (ARGX) have?

In our weekly check, argenx SE is graded A (A to F). Of 23 checks on debt, profit, cash flow and trend: 19 pass, warnings: 4, red flags: 0. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of ARGX stock?

This week's biggest flags for argenx SE: Profits not backed by cash, High P/E, Very volatile. In total 4 of 23 checks show a warning or a red flag.

What does argenx SE do?

argenx SE is a Healthcare company (Biotechnology) based in the Netherlands, listed on NASDAQ as ARGX.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis